Document:

EX-10.3

 Exhibit 10.3 

SECOND AMENDMENT TO LICENSE AGREEMENT 

This AMENDMENT TO LICENSE AGREEMENT (“Amendment”) is entered into as of February 25, 2014 (the “Amendment
Effective Date”), by and between Alfred E. Mann Foundation for Scientific Research (“AMF”) and Axonics Modulation Technologies, Inc., a Delaware corporation (“Licensee”). 

RECITALS 
 WHEREAS,
AMF and License are parties to that certain License Agreement, dated as of October 1, 2013 and that certain Amendment dated February 18, 2014 (together the “License Agreement”), pursuant to which AMF granted Licensee
certain rights to develop and commercialize Epione; 
 WHEREAS, the License Agreement is incorporated herein by reference; and 

WHEREAS, as a condition to the Series A Financing, the investors have requested that Licensee and AMF further amend Schedule A of the
License Agreement as set forth hereunder. 
 AGREEMENT 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties agree to this Amendment as follows: 

1. Defined Terms. The capitalized terms used but not defined herein have the respective meanings ascribed to them in
the License Agreement 
 2. Amendment of Schedule A. Schedule A of the Agreement shall be amended and replaced in its
entirety with Schedule A attached as Exhibit A to this Amendment. 
 3. Continuing Effect. All references to the
“Agreement” in the License Agreement shall hereinafter refer to the Agreement as amended by this Amendment. Except as specifically amended by this Amendment, the License Agreement shall remain in full force and
effect in accordance with its terms. Sections or other headings contained in this Amendment are for reference purposes only and shall not affect in any way the meaning or interpretation of this Amendment; and no provision of this Amendment shall be
interpreted for or against any party because that party or its legal representative drafted the provision. 
 4. Counterparts.
This Amendment may be executed in counterparts, each of which will be considered an original, but all of which together will constitute the same instrument. 

[Signature Page Follows] 
  

  
 Confidential treatment has been
requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 

  

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed
as of the day and year first set forth above. 
  

			
	ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
		
	By:	 	/s/ David Hankin
		
	Name:	 	David Hankin
		
	Title:	 	CEO
		
	Date:	 	February 25, 2014

  

			
	AXONICS MODULATION TECHNOLOGIES, INC.
		
	By:	 	/s/ Michael Williamson
		
	Name:	 	Michael Williamson
		
	Title:	 	SVP/General Counsel
		
	Date:	 	February 25, 2014

  

  
 Confidential treatment has been
requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 

  
 2 

 EXHIBIT A 

SCHEDULE A TO THE LICENSE AGREEMENT 
  

							
	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

	 [***]
	  	 [***]
	  	 [***]
	  	 [***]

  

  
 Confidential treatment has been
requested for portions of this exhibit under 17 C.F.R. Sections §§ 200.80(b)(4) and 230.406. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version
of this exhibit has been filed separately with the Securities and Exchange Commission. 

  
 3EX-10.4

 Exhibit 10.4 

ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH 

25 134 Rye Canyon Loop 
 Santa
Clarita, CA 91355 
 October 1, 2013 
 Axonics Modulation
Technologies, Inc. 
 16411 Scientific Way 
 Suite 200 

Irvine, CA 92618 
 Dear Sirs: 

Reference is made to that certain License Agreement of even date herewith between Axonics Modulation Technologies, Inc. and the undersigned. This will confirm
that at your option the undersigned will expand the territories included under the license to be worldwide or, if you so direct, the undersigned will enter into a comparable license agreement covering areas outside the United States with an entity
controlled by the founders of Axonics Modulation Technologies, Inc. In the latter case, such license would be based on economic and other terms, other than the territory covered, as is set forth in the License Agreement. 

Very truly yours, 
 Alfred E. Mann Foundation for Scientific
Research 
  

			
		
	By:	 	/s/ John G. Petrovich
		 	Name: John G. Petrovich
		 	Title: General CounselEX-10.5

 Exhibit 10.5 

AXONICS MODULATION TECHNOLOGIES, INC. 

2014 STOCK INCENTIVE PLAN 

This 2014 Stock Incentive Plan (the “Plan”) is hereby established by Axonics Modulation Technologies, Inc., a Delaware
corporation (the “Company”), and adopted by its Board of Directors as of March 12 2014 (the “Effective Date”). 

ARTICLE 1. 
 PURPOSES OF
THE PLAN 
 1.1 Purposes. The purposes of the Plan are (a) to enhance the Company’s ability to
attract and retain the services of qualified employees, officers and directors (including non-employee officers and directors), and consultants and other service providers upon whose judgment, initiative and
efforts the successful conduct and development of the Company’s business largely depends, and (b) to provide additional incentives to such persons or entities to devote their utmost effort and skill to the advancement and betterment
of the Company, by providing them an opportunity to participate in the ownership of the Company and thereby have an interest in the success and increased value of the Company. 

ARTICLE 2. 
 DEFINITIONS

 For purposes of this Plan, the following terms shall have the meanings indicated: 

2.1 Administrator. “Administrator” means the Board or, if the Board delegates responsibility for any matter to
the Committee, the term Administrator shall mean the Committee. 
 2.2 Affiliated Company. “Affiliated
Company” means any “parent corporation” or “subsidiary corporation” of the Company, whether now existing or hereafter created or acquired, as those terms are defined in Sections 424(e) and 424(f) of the Code, respectively.

 2.3 Award. “Award” means any Option or Restricted Stock granted to a Participant under the Plan. 

2.4 Award Agreement. “Award Agreement” means any Option Agreement or Restricted Stock Purchase Agreement
entered into between the Company and a Participant under the Plan. 
 2.5 Board. “Board” means the Board of
Directors of the Company. 
 2.6 Cause. “Cause” shall, unless otherwise defined in a Participant’s
written employment agreement or Award Agreement, mean: (a) the commission of any act of fraud, embezzlement or dishonesty by Participant which adversely affects the business of the Company, the acquiring or successor entity (or parent or
any subsidiary thereof), (b) any unauthorized use or disclosure by Participant of confidential information or trade secrets of the Company, the acquiring or successor entity (or parent or any subsidiary thereof), (c) any act or omission by the
Participant involving malfeasance or gross negligence in the performance of Participant’s duties to, or deviation from any of the policies or directives of, the Company or the acquiring or successor entity (or parent or any subsidiary thereof),
or (d) any illegal act by Participant which adversely affects the business of the Company, the acquiring or successor entity (or parent or any subsidiary thereof), or any felony committed by Participant, as evidenced by conviction
thereof 

 2.7 Change in Control. “Change in Control” means the
occurrence of any of the following: 
 (a) The acquisition, directly or indirectly, in one transaction or a series of related
transactions, by any person or group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) of the beneficial ownership of securities of the Company possessing more than fifty percent (50%) of the
total combined voting power of all outstanding securities of the Company, provided, however if a person or group is considered to own securities of the Company possessing more than fifty percent (50%) of the total combined voting power of the
securities of the Company and such person or group acquires additional securities of the Company, the acquisition of additional securities by such person or group shall not be considered to cause a Change in Control of the Company; 

(b) The consummation of a merger or consolidation in which the Company is not the surviving entity, except for a transaction in which
the holders of the outstanding voting securities of the Company immediately prior to such merger or consolidation hold as a result of holding Company securities prior to such transaction, in the aggregate, securities possessing at least fifty
percent (50%) of the total combined voting power of all outstanding voting securities of the surviving entity immediately after such merger or consolidation; 

(c) A reverse merger in which the Company is the surviving entity but in which the holders of the outstanding voting securities of the
Company immediately prior to such merger hold, in the aggregate, securities possessing less than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the acquiring entity immediately after
such merger; or 
 (d) The sale, transfer or other disposition (in one transaction or a series of related transactions) of all or
substantially all of the assets of the Company, except for a transaction in which the holders of the outstanding voting securities of the Company immediately prior to such transaction(s) receive as a distribution with respect to securities of the
Company, in the aggregate, securities possessing at least fifty percent (50%) of the total combined voting power of all outstanding voting securities of the acquiring entity immediately after such transaction(s). 

2.8 Code. “Code” means the Internal Revenue Code of 1986, as amended from time to time, and applicable Treasury
Regulations and administrative guidance promulgated thereunder. 
 2.9 Committee. “Committee” means a
committee of two or more members of the Board appointed to administer the Plan pursuant to Section 7.1 hereof. 
 2.10
Common Stock. “Common Stock” means the Common Stock of the Company. 
 2.11 Company.
“Company” shall have the meaning set forth in the preamble to this Plan. 
 2.12 Consultant.
“Consultant” means any consultant or advisor if: (a) the consultant or advisor renders bona fide services to the Company or any Affiliated Company; (b) the services rendered by the consultant or advisor are not in connection
with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company’s securities; and (c) the consultant or advisor is a natural person who has
contracted directly with the Company or any Affiliated Company to render such services. 

  
 2 

 2.13 Continuous Service. Unless otherwise provided in an Award
Agreement, the terms of which may be different from the following, “Continuous Service” means (a) Participant’s employment by either the Company or any Affiliated Company, or by successor entity following a Change in Control,
which is uninterrupted except for vacations, illness (not including permanent Disability), or leaves of absence which are approved in writing by the Company or any of such other employer entities, as applicable, (b) service as a member of the
Board until the Participant resigns, is removed from office, or Participant’s term of office expires and he or she is not reelected, or (c) so long as the Participant is engaged as a Consultant or other Service Provider. 

2.14 Disability. “Disability” means permanent and total disability as defined in Section 22(e)(3) of the
Code. The Administrator’s determination of a Disability or the absence thereof shall be conclusive and binding on all interested parties. 

2.15 Effective Date. “Effective Date” shall have the meaning set forth in the preamble to this Plan. 

2.16 Established Securities Market. “Established Securities Market” means either: (a) a securities
exchange registered with the Securities and Exchange Commission under Section 6 of the Exchange Act; (b) a foreign national securities exchange officially recognized, sanctioned or supervised by governmental authority; or (c) an
OTC Market. 
 2.17 Exchange Act. “Exchange Act” means the Securities and Exchange Act of 1934, as amended.

 2.18 Exercise Price. “Exercise Price” means the purchase price per share of Common Stock payable upon
exercise of an Option. 
 2.19 Fair Market Value. “Fair Market Value” on any given date means the value of a
share of Common Stock, determined as follows: 
 (a) If the Common Stock is then readily tradable on an Established
Securities Market, the Fair Market Value shall be determined by the Administrator through the application of a valuation method permitted under Treasury Regulation Section 1.409A-1(b)(5)(iv)(A); and

 (b) If the Common Stock is not then readily tradable on an Established Securities Market, the Fair Market Value shall be
determined by the Administrator in good faith through the reasonable application of a reasonable valuation method in accordance with Treasury Regulation Section 1.409A-1(b)(5)(iv)(B), which
determination shall be conclusive and binding on all interested parties. 
 2.20 FINRA Dealer. “FINRA Dealer”
means a broker-dealer that is a member of the Financial Industry Regulatory Authority, Inc. 
 2.21 Incentive Option.
“Incentive Option” means any Option designated and qualified as an “incentive stock option” as defined in Section 422 of the Code. 

2.22 New Incentives. “New Incentives” shall have the meaning set forth in Section 8.1(a) hereof 

  
 3 

 2.23 Nonqualified Option. “Nonqualified Option” means any
Option that is not an Incentive Option. To the extent any Option designated as an Incentive Option fails in whole or in part to qualify as an Incentive Option, including without limitation, for failure to meet the requirements applicable to 10%
Stockholders or because the annual limit described in Section 5.6 hereof is exceeded, it shall to that extent constitute a Nonqualified Option. 

2.24 Option. “Option” means any option to purchase Common Stock granted pursuant to Article 5 hereof. 

2.25 Option Agreement. “Option Agreement” means the written agreement entered into between the Company and an
Optionee with respect to an Option granted under the Plan. 
 2.26 Optionee. “Optionee” means a Participant
who holds an Option. 
 2.27 OTC Market. “OTC Market” means an over-the-counter market reflected by the existence of an interdealer quotation system. 

2.28 Participant. “Participant” means an individual that holds an Option or Restricted Stock granted pursuant
to the Plan. 
 2.29 Performance Criteria. “Performance Criteria” means one or more of the following as
established by the Administrator, which may be stated as a target percentage or dollar amount, a percentage increase over a base period percentage or dollar amount or the occurrence of a specific event or events: 

(a) Revenue; 

(b) Gross profit; 

(c) Operating income; 

(d) Pre-tax income; 

(e) Earnings before interest, taxes, depreciation and amortization (“EBITDA”); 

(f) Earnings per common share on a fully diluted basis (“EPS”); 

(g) Consolidated net income of the Company divided by the average consolidated common stockholders’ equity
(“ROE”); 
 (h) Cash and cash equivalents derived from either (i) net cash flow from operations, or
(ii) net cash flow from operations, financings and investing activities (“Cash Flow”); 
 (i) Adjusted operating
cash flow return on income; 
 (j) Cost containment or reduction; 

(k) The percentage increase in the market price of the Company’s common stock over a stated period; and 

(l) Individual business objectives. 

2.30 Plan. “Plan” means this 2014 Stock Incentive Plan of the Company. 

  
 4 

 2.31 Publicly Held. “Publicly Held” means, with respect to
the Company, any point in time in which any class of common equity securities of the Company are required to be registered under Section 12 of the Exchange Act. 

2.32 Purchase Price. “Purchase Price” means the purchase price payable to purchase a share of Restricted Stock.

 2.33 Repurchase Rights. “Repurchase Rights” means the right of the Company to repurchase shares of Common
Stock issued pursuant to an Award granted under the Plan. 
 2.34 Restricted Stock. “Restricted Stock” means
shares of Common Stock issued pursuant the Plan, subject to any restrictions and conditions as are established pursuant to Article 6. 

2.35 Restricted Stock Purchase Agreement. “Restricted Stock Purchase Agreement” means the written agreement
entered into between the Company and a Participant with respect to the purchase of Restricted Stock under the Plan. 
 2.36
Securities Act. “Securities Act” means the Securities Act of 1933, as amended. 
 2.37 Service
Provider. “Service Provider” means a Consultant or other natural person the Administrator authorizes to become a Participant in the Plan and who provides services to: (a) the Company; (b) an Affiliated Company;
or (c) any other business venture designated by the Administrator in which the Company (or any entity that is a successor to the Company) or an Affiliated Company has a significant ownership interest. 

2.38 10% Stockholder. “10% Stockholder” means a person who, as of a relevant date, owns or is deemed to own (by
reason of the attribution rules applicable under Section 424(d) of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or of an Affiliated Company measured as of an Incentive
Option’s date of grant. 
 2.39 Treasury Regulations. “Treasury Regulations” shall mean the regulations
of the United States Treasury Department promulgated under the Code. 
 ARTICLE 3. 

ELIGIBILITY 
 3.1
Incentive Options. Only employees of the Company or of an Affiliated Company (including officers of the Company and members of the Board if they are employees of the Company or of an Affiliated Company) are eligible to receive
Incentive Options under the Plan. 
 3.2 Nonqualified Options and Restricted Stock. Employees of the Company or of an
Affiliated Company, members of the Board (whether or not employed by the Company or an Affiliated Company), and Service Providers are eligible to receive Nonqualified Options and Restricted Stock under the Plan. 

3.3 Section 162(m) Limitation. On and after such time, if any, that the Company is Publicly Held, no employee of the
Company or of an Affiliated Company shall be eligible to be granted Options covering more than 1,000,000 shares of Common Stock during any calendar year; provided, however, the preceding limitation shall not apply until the earliest time required
for compensation attributable to Options granted under the Plan to be exempt from the deduction limitation of Section 162(m) of the Code. 

  
 5 

 ARTICLE 4. 

PLAN SHARES 
 4.1
Shares Subject to the Plan. As of the Effective Date, there are 460,000 total shares of Common Stock available for issuance under the Plan. For purposes of this Section 4.1, in the event that (a) all or any portion of any
Award granted or offered under the Plan can no longer under any circumstances be exercised or (b) any shares of Common Stock are reacquired by the Company which were initially the subject of an Award Agreement, the shares of Common Stock
allocable to the unexercised portion of such Award, or the shares so reacquired, shall again be available for grant or issuance under the Plan. The maximum number of shares of Common Stock that may be issued under the Plan as Incentive Options shall
be 460,000 shares, subject to adjustment as to the number and kind of shares pursuant to Section 4.2. 
 4.2 Changes in
Capital Structure. In the event that the outstanding shares of Common Stock are hereafter increased or decreased or changed into or exchanged for a different number or kind of shares or other securities of the Company by reason of a
recapitalization, stock split, reverse stock split, combination of shares, reclassification, stock dividend, or other change in the capital structure of the Company, then appropriate adjustments shall be automatically made to the aggregate number
and kind of shares subject to this Plan, the number and kind of shares and the Exercise Price or Purchase Price per share subject to outstanding Award Agreements, and the limits on the number of shares under Sections 3.3 and 4.1 hereof, all in order
to preserve, as nearly as practical, but not to increase, the benefits to Participants. 
 ARTICLE 5. 

OPTIONS 
 5.1
Option Agreement. Each Option granted pursuant to this Plan shall be evidenced by an Option Agreement that shall specify the number of shares subject thereto, the Exercise Price per share, and whether the Option is an Incentive Option
or Nonqualified Option. As soon as is practical following the grant of an Option, an Option Agreement shall be duly executed and delivered by or on behalf of the Company to the Optionee to whom such Option is granted. Each Option Agreement shall be
in the form attached hereto as Exhibit A and contain such additional or specific terms and conditions as the Administrator shall, from time to time, deem desirable. With respect to terms unspecified in such form Option Agreement, an Option Agreement
may be different from each other Option Agreement provided that all permitted variations in the terms of any Option Agreement permitted by this Article 5 shall be subject to the general requirement that the grant be made pursuant to the form Option
Agreement. 
 5.2 Exercise Price. The Exercise Price per share of Common Stock covered by each Option shall be
determined by the Administrator, provided that (a) the Exercise Price shall not be less than 100% of the Fair Market Value per share of Common Stock on the date the Option is granted, and (b) in the case of an Incentive Option granted
to a 10% Stockholder, the Exercise Price shall not be less than 110% of the Fair Market Value per share of Common Stock on the date the Incentive Option is granted. However, an Option may be granted with an Exercise Price lower than that set forth
in the preceding sentence if such Option is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Sections 424 of the Code, as applicable. 

  
 6 

 5.3 Payment of Exercise Price. Payment of the Exercise Price or the
Purchase Price shall be made upon exercise of an Option or the purchase of Restricted Stock and may be made, in the discretion of the Administrator , subject to any restrictions under applicable law, by: 

(a) check or cash; 

(b) surrender of shares of Common Stock acquired pursuant to the exercise of an Option, which surrendered shares shall be valued at
Fair Market Value as of the date of such exercise; 
 (c) delivery of a promissory note in a form and with such recourse, interest,
security and other provisions as set forth in the form of an exhibit to the form of Restricted Stock Purchase Agreement and with such other terms as the Administrator determines to be appropriate (subject to applicable law), provided that the option
to make payment pursuant to this Section 5.3(c) shall always be available to a Participant that is any of (i) an executive officer, (ii) a director level employee or (iii) a Consultant of the Company with
similar status to either (i) or (ii); 
 (d) cancellation of indebtedness of the Company to the Optionee; 

(e) waiver of compensation due or accrued to the Optionee for services rendered; 

(f) provided that a public market for the Common Stock exists, a “same day sale” commitment from the Optionee and a FINRA
Dealer whereby the Optionee irrevocably elects to exercise the Option and to sell a portion of the shares so purchased to pay for the Exercise Price and whereby the FINRA Dealer irrevocably commits upon receipt of such shares to forward the Exercise
Price directly to the Company; 
 (g) provided that a public market for the Common Stock exists, a “margin” commitment
from the Optionee and a FINRA Dealer whereby the Optionee irrevocably elects to exercise the Option and to pledge the shares so purchased to the FINRA Dealer in a margin account as security for a loan from the FINRA Dealer in the amount of the,
Exercise Price, and whereby the FINRA Dealer irrevocably commits upon receipt of such shares to forward the Exercise Price directly to the Company; 

(h) a “net exercise” arrangement pursuant to which the Company will reduce the number of shares of Common Stock to be issued
upon exercise by the number of shares of Common Stock having an aggregate Fair Market Value as of the date of exercise equal to the total Exercise Price. The shares of Common Stock used to pay the Exercise Price under this “net exercise”
provision shall be considered to have resulted from the exercise of this Option, and accordingly, this Option will not again be exercisable with respect to such shares of Common Stock, as well as any shares of Common Stock actually delivered to
Optionee; or 
 (i) any combination of the foregoing methods of payment or any other consideration or method of payment as shall be
permitted by applicable law. 
 5.4 Term and Termination of Options. The term and provisions for termination of each
Option shall be as fixed by the Administrator, but no Option may be exercisable more than ten (10) years after the date it is granted. An Incentive Option granted to a person who is a 10% Stockholder on the date of grant shall not be
exercisable more than five (5) years after the date it is granted. 
 5.5 Vesting and Exercise of Options. Each
Option shall vest and become exercisable in one or more installments at such time or times and subject to such conditions, including without limitation, the achievement of specified performance goals or objectives, as shall be determined by the

  
 7 

 
Administrator. Notwithstanding the foregoing, each Option granted to an employee of the Company or Affiliated Company shall provide that the employee shall have the right to exercise the vested
portion of any Option held at the termination of the employee’s Continuous Service for at least ninety (90) days following termination of the employee’s Continuous Service for any reason other than Cause and that the employee (or
employee’s designee) shall have the right to exercise the Option for at least six (6) months if such termination of employee’s Continuous Service is due to the death or Disability of the employee. 

5.6 Annual Limit on Incentive Options. To the extent required for “incentive stock option” treatment under
Section 422 of the Code, if the aggregate Fair Market Value (determined as of the date of grant) of the Common Stock with respect to which Incentive Options granted under this Plan and any other plan of the Company or any Affiliated Company
becomes exercisable for the first time by an Optionee during any calendar year exceeds $100,000, such excess shall be a Nonqualified Option. 

5.7 Nontransferability of Options. Except as otherwise provided by the Administrator in an Option Agreement and as
permissible under applicable law, no Option shall be assignable or transferable except by will or the laws of descent and distribution, and during the life of the Optionee shall be exercisable only by such Optionee. Notwithstanding the forgoing, the
Administrator may grant Nonqualified Options that may be transferred to a revocable trust or as otherwise permitted under Rule 701 of the Securities Act. 

5.8 Rights as Stockholder. An Optionee or permitted transferee of an Option shall have no rights or privileges as a
stockholder with respect to any shares covered by an Option until such Option has been duly exercised and shares purchased upon such exercise have been issued to such person. 

5.9 Unvested Shares. The Administrator shall have the discretion to grant Options that are exercisable for unvested
shares of Common Stock on such terms and conditions as the Administrator shall determine from time to time. 
 5.10
Company’s Repurchase Right. In the event of a termination of an Optionee’s Continuous Service for any reason whatsoever (including death or Disability), the Option Agreement may provide, in the discretion of the
Administrator, that the Company, or its assignee, shall have the right, exercisable at the discretion of the Administrator, to repurchase shares of Common Stock acquired pursuant to the exercise of an Option at any time, on such terms as may be
provided in the Option Agreement. The repurchase price for shares repurchased by the Company shall be as set forth in the document evidencing the Repurchase Right, subject to the following requirements: 

(a) In the case of vested shares, the repurchase price shall be equal to the Fair Market Value per share of Common Stock as of the
date of termination of Optionee’s Continuous Service; and 
 (b) In the case of unvested shares, the repurchase price may be
equal to one of the following: (i) the Fair Market Value per share of Common Stock as of the date of termination of Optionee’s Continuous Service, (ii) the Exercise Price paid per share, or (iii) the lesser of
(A) the Exercise Price paid per share, or (B) the Fair Market Value per share of Common Stock as of the date of termination of Optionee’s Continuous Service. 

The terms upon which the Company’s Repurchase Right shall be exercisable (including but not limited to the period and procedure for
exercise and the timing and method of payment for the purchased shares) shall be established by the Administrator and set forth in the document evidencing such Repurchase Right. 

  
 8 

 5.11 Compliance with Code
Section 409A. Notwithstanding anything in this Article 5 to the contrary, all Options are intended to be structured to satisfy the requirements of Code Section 409A, or an applicable exemption, as
determined by the Administrator. 
 ARTICLE 6. 

RESTRICTED STOCK 

6.1 Issuance and Sale of Restricted Stock. The Administrator shall have the authority to grant Restricted Stock under
this Plan, subject to such terms, restrictions and conditions as the Administrator may determine at the time of grant as limited by this Article 6. 

6.2 Restricted Stock Purchase Agreements. A Participant shall have no rights with respect to the shares of Restricted
Stock covered by a Restricted Stock Purchase Agreement until the Participant has executed and delivered to the Company the Restricted Stock Purchase Agreement. Each Restricted Stock Purchase Agreement shall be in the form attached hereto as Exhibit
B and contain such additional terms and conditions as the Administrator shall, from time to time, deem desirable. With respect to terms unspecified in such form Restricted Stock Purchase Agreement, a Restricted Stock Purchase Agreement may be
different from other Restricted Stock Purchase Agreements provided that all permitted variations in the terms of any Restricted Stock Purchase Agreement permitted by this Article 6 shall be subject to the general requirement that the grant be made
pursuant to the form Restricted Stock Purchase Agreement. 
 6.3 Rights as a Stockholder. Upon complying with the
provisions of Section 6.2 hereof, a Participant shall have the rights of a stockholder with respect to the Restricted Stock purchased pursuant to a Restricted Stock Purchase Agreement, including voting and dividend rights, subject to the
terms, restrictions and conditions as are set forth in such Restricted Stock Purchase Agreement. Unless the Administrator shall determine otherwise, certificates evidencing shares of Restricted Stock shall remain in the possession of the Company
until such shares have vested in accordance with the terms of the Restricted Stock Purchase Agreement. 
 6.4 Transfer
Restrictions. Shares of Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided in the Restricted Stock Purchase Agreement. 

6.5 Company’s Repurchase Right. In the event of a termination of a Participant’s Continuous Service with the
Company for any reason whatsoever (including death or Disability), the Restricted Stock Purchase Agreement may provide, in the discretion of the Administrator, that the Company shall have the right, exercisable at the discretion of the
Administrator, to repurchase shares of Common Stock acquired pursuant to a Restricted Stock Purchase Agreement, on such terms as may be provided in the Restricted Stock Purchase Agreement. The repurchase price for shares repurchased by the Company
shall be as set forth in the document evidencing the Repurchase Right, subject to the following requirements: 
 (a) In the case of
vested shares, the repurchase price shall be equal to the Fair Market Value per share of Common Stock as of the date of termination of Participant’s Continuous Service; and 

(b) In the case of unvested shares, the repurchase price may be equal to one of the following: (i) the Fair Market Value
per share of Common Stock as of the date of termination of Participant’s Continuous Service, (ii) the original Purchase Price paid per share, if any, or (iii) the lesser of (A) the original Purchase Price
paid per share, if any, or (B) the Fair Market Value per share of Common Stock as of the date of termination of Participant’s Continuous Service. 

  
 9 

 The terms upon which such Repurchase Right shall be exercisable (including but not limited
to the period and procedure for exercise and the timing and method of payment for the purchased shares) shall be established by the Administrator and set forth in the document evidencing such Repurchase Right. 

6.6 Vesting of Restricted Stock. The Restricted Stock Purchase Agreement shall specify the date or dates, the Performance
Criteria or objectives which must be achieved, and any other conditions on which the Restricted Stock may vest. 
 6.7
Compliance with Code Section 409A. Notwithstanding anything in this Article 6 to the contrary, all Restricted Stock Awards are intended to be structured to satisfy the requirements of Code
Section 409A, or an applicable exemption, as determined by the Administrator. 
 ARTICLE 7. 

ADMINISTRATION OF THE PLAN 

7.1 Administrator. Authority to control and manage the operation and administration of the Plan shall be vested in the
Board, which may delegate such responsibilities in whole or in part to a Committee of the Board. Members of the Committee may be appointed from time to time by, and shall serve at the pleasure of, the Board. The Board may limit the composition of
the Committee to those persons necessary to comply with the requirements of Section 162(m) of the Code and Section 16 of the Exchange Act. 

7.2 Powers of the Administrator. In addition to any other powers or authority conferred upon the Administrator elsewhere
in the Plan or by applicable law, the Administrator shall have full power and authority: (a) to determine the persons to whom, and the time or times at which Awards shall be granted, the number of shares of Common Stock to be represented
by each Option Agreement and the number of shares of Common Stock to be subject to each Restricted Stock Purchase Agreement, and the consideration to be received by the Company upon the exercise of such Options or sale of Restricted Stock;
(b) to interpret the Plan; (c) to create, amend or rescind rules and regulations relating to the Plan; (d) to determine the terms, conditions and restrictions contained in, and the form of, Award Agreements;
(e) to determine the identity or capacity of any persons who may be entitled to exercise a Participant’s rights under any Award Agreement under the Plan; (0 to correct any defect or supply any omission or reconcile any inconsistency
in the Plan or in any Award Agreement; (g) to accelerate the vesting of any Award or release or waive any Repurchase Rights of the Company with respect to any Award; (h) to extend the exercise date of any Option (but not
beyond the original expiration date); (i) to provide for rights of first refusal and/or Repurchase Rights; (j) to amend outstanding Award Agreements to provide for, among other things, any change or modification which the Administrator
could have included in the original Award Agreement or in furtherance of the powers provided for herein; and (k) to make all other determinations necessary or advisable for the administration of the Plan, but only to the extent not
contrary to the express provisions of the Plan. Any action, decision, interpretation or determination made in good faith by the Administrator in the exercise of its authority conferred upon it under the Plan shall be final and binding on the Company
and all Participants. 
 7.3 Section 409A of the Code. Notwithstanding anything in this Plan to the contrary,
(a) any adjustments made pursuant to this Article 8 to Awards that are considered “deferred compensation” within the meaning of Section 409A of the Code shall be made in compliance with the

  
 10 

 
requirements of Section 409A of the Code; (b) any adjustments made pursuant to Article 8 to Awards that are not considered “deferred compensation” subject to
Section 409A of the Code shall be made in such a manner as to ensure that after such adjustment the Awards either (i) continue not to be subject to Section 409A of the Code or (ii) comply with the requirements of
Section 409A of the Code; and (c) in any event, the Administrator shall not have the authority to make any adjustments pursuant to Article 8 to the extent the existence of such authority would cause an Award that is not
intended to be subject to Section 409A of the Code at the time of grant to be subject thereto. 
 7.4 Limitation on
Liability. No employee of the Company or member of the Board or Committee shall be subject to any liability with respect to duties under the Plan unless the person acts fraudulently or in bad faith. To the extent permitted by applicable law,
the Company shall indemnify each member of the Board or Committee, and any employee of the Company with duties under the Plan, who was or is a party, or is threatened to be made a party, to any threatened, pending or completed proceeding, whether
civil, criminal, administrative or investigative, by reason of such person’s conduct in the performance of duties under the Plan. 

ARTICLE 8. 
 CHANGE IN
CONTROL 
 8.1 Change in Control. In order to preserve a Participant’s rights with respect to any outstanding
Awards in the event of a Change in Control of the Company the Administrator shall provide that (i) the vesting for all outstanding Options shall accelerate automatically effective as of immediately prior to the consummation of a Change
in Control and (ii) all Repurchase Rights shall automatically terminate immediately prior to the consummation of a change in Control and the Shares subject to those terminated Repurchase Rights shall immediately vest in full. 

ARTICLE 9. 
 AMENDMENT
AND TERMINATION OF THE PLAN 
 9.1 Amendments. The Board may from time to time alter, amend, suspend or terminate
the Plan in such respects as the Board may deem advisable. No such alteration, amendment, suspension or termination shall be made which shall (i) substantially affect or impair the rights of any Participant under an outstanding Award
Agreement without such Participant’s consent, or (ii) cause this Plan, or any Award granted pursuant to it, to violate Code Section 409A. The Board may alter or amend the Plan to comply with requirements under the Code
relating to Incentive Options or other types of options that give Optionees more favorable tax treatment than that applicable to Options granted under this Plan as of the date of its adoption. Upon any such alteration or amendment, any outstanding
Award granted hereunder may, if the Administrator so determines and if permitted by applicable law, be subject to the more favorable tax treatment afforded to a Participant pursuant to such terms and conditions. 

9.2 Plan Termination. Unless the Plan shall theretofore have been terminated, the Plan shall terminate on the tenth
(10th) anniversary of the Effective Date and no Awards may be granted under the Plan thereafter, but Award Agreements then outstanding shall continue in effect in accordance with their respective terms. 

  
 11 

 ARTICLE 10. 

TAXES 
 10.1
Tax Withholding. The Company shall have the power to withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy any applicable Federal, state, and local tax withholding requirements with respect to any
Options exercised or shares of Restricted Stock issued under this Plan. To the extent permissible under applicable tax, securities and other laws, the Administrator may, in its sole discretion and upon such terms and conditions as it may deem
appropriate, permit a Participant to satisfy his or her obligation to pay any such tax, in whole or in part, by (a) directing the Company to apply shares of Common Stock to which the Participant is entitled as a result of the exercise of
an Option or lapse of restrictions on shares of Restricted Stock or (b) delivering to the Company shares of Common Stock owned by the Participant; provided, however, the amount withheld shall not exceed the amount necessary to satisfy
the Company’s tax withholding obligations at the minimum statutory withholding rates, as applicable. The shares of Common Stock so applied or delivered in satisfaction of the Participant’s tax withholding obligation shall be valued at
their Fair Market Value as of the date of measurement of the amount of income subject to withholding. 
 ARTICLE 11. 

MISCELLANEOUS 

11.1 Benefits Not Alienable. Other than as provided above, benefits under the Plan may not be assigned or alienated,
whether voluntarily or involuntarily. Any unauthorized attempt at assignment, transfer, pledge or other disposition shall be without effect. 

11.2 No Enlargement of Employee Rights. This Plan is strictly a voluntary undertaking on the part of the Company and
shall not be deemed to constitute a contract between the Company and any Participant to be consideration for, or an inducement to, or a condition of, the employment of any Participant. Nothing contained in the Plan shall be deemed to give the right
to any Participant to be retained as an employee of the Company or any Affiliated Company or to limit the right of the Company or any Affiliated Company to discharge any Participant at any time. 

11.3 Application of Funds. The proceeds received by the Company from the sale of Common Stock pursuant to Option
Agreements and Restricted Stock Purchase Agreements, except as otherwise provided herein, will be used for general corporate purposes. 

11.4 Financial Reports. To the extent required by Rule 701(e) of the Securities Act, the Company shall provide, at least
annually, summary financial information relating to the Company’s financial condition and results of operations to each Participant who holds one or more Awards or shares of Common Stock issued pursuant to the Plan. 

11.5 Stockholder Approval. The Company shall obtain stockholder approval of the Plan within twelve
(12) months before or after the adoption of the Plan by the Board of Directors. 

  
 12 

 FIRST AMENDMENT 

TO 
 AXONICS MODULATION
TECHNOLOGIES, INC. 
 2014 STOCK INCENTIVE PLAN 

In accordance with those certain resolutions adopted by the Board of Directors and Stockholders of Axonics Modulation Technologies, Inc., a
Delaware corporation (the “Company”), the 2014 Stock Incentive Plan (the “Plan”) of the Company is hereby amended as follows: 

1. Section 4.1 of the Plan is hereby amended and restated in its entirety to increase the number of shares reserved for issuance under the Plan as follows:

 “4.1 Shares Subject to the Plan. As of the Effective Date, there are 1,413,395 total shares of Common Stock
available for issuance under the Plan. For purposes of this Section 4.1, in the event that (a) all or any portion of any Award granted or offered under the Plan can no longer under any circumstances be exercised or (b) any shares of
Common Stock are reacquired by the Company which were initially the subject of an Award Agreement, the shares of Common Stock allocable to the unexercised portion of such Award, or the shares so reacquired, shall again be available for grant or
issuance under the Plan. The maximum number of shares of Common Stock that may be issued under the Plan as Incentive Options shall be 1,413,395 shares, subject to adjustment as to the number and kind of shares pursuant to Section 4.2.”

 2. Unless otherwise expressly provided for in this First Amendment to the Plan (the “First Amendment”), all capitalized words, phrases,
or defined terms used in this First Amendment will have the same meaning ascribed to them in the Plan. 
 3. Except as expressly set forth in this First
Amendment, there have been no other changes or modifications to the Plan, and the plan remains otherwise unchanged and in full force and effect. 
 4. This
First Amendment shall be effective as of December 4, 2015. 
 I hereby certify that the Plan was duly amended and such First Amendment
has been duly approved by the Board of Directors of the Company as of December 4, 2015 and such First Amendment has been duly approved by the Stockholders of the Company as of December 4, 2015. 

[Remainder of Page Intentionally Left Blank; Signature Page to Follow] 

 IN WITNESS WHEREOF, the undersigned has caused this First Amendment to be executed effective
as of the date set forth above. 
  

			
	 AXONICS MODULATION TECHNOLOGIES, INC.,

A Delaware corporation

 
			
		
	By:	 	/s/ Raymond W. Cohen
	Name:	 	Raymond W. Cohen
	Title:	 	CEO

 Signature Page to First Amendment to the Plan 

 SECOND AMENDMENT 

TO 
 AXONICS MODULATION
TECHNOLOGIES, INC. 
 2014 STOCK INCENTIVE PLAN 

In accordance with those certain resolutions adopted by the Board of Directors and Stockholders of Axonics Modulation Technologies, Inc., a
Delaware corporation (the “Company”), the 2014 Stock Incentive Plan (the “Plan”) of the Company is hereby further amended as follows: 

1. Section 4.1 of the Plan is hereby amended and restated in its entirety to increase the number of shares reserved for issuance under the
Plan as follows: 
 “4.1 Shares Subject to the Plan. As of the Effective Date, there are 1,651,976 total shares of
Common Stock available for issuance under the Plan. For purposes of this Section 4.1, in the event that (a) all or any portion of any Award granted or offered under the Plan can no longer under any circumstances be exercised or
(b) any shares of Common Stock are reacquired by the Company which were initially the subject of an Award Agreement, the shares of Common Stock allocable to the unexercised portion of such Award, or the shares so reacquired, shall again be
available for grant or issuance under the Plan. The maximum number of shares of Common Stock that may be issued under the Plan as Incentive Options shall be 1,651,976 shares, subject to adjustment as to the number and kind of shares pursuant to
Section 4.2.” 
 2. Unless otherwise expressly provided for in this Second Amendment to the Plan (the “Second
Amendment”), all capitalized words, phrases, or defined terms used in this Second Amendment will have the same meaning ascribed to them in the Plan. 

3. Except as expressly set forth in this Second Amendment, there have been no other changes or modifications to the Plan, and the plan remains
otherwise unchanged and in full force and effect. 
 4. This Second Amendment shall be effective as of April 28, 2017. 

I hereby certify that the Plan was duly amended and such Second Amendment has been duly approved by the Board of Directors of the Company as
of April 19, 2017 and such Second Amendment has been duly approved by the Stockholders of the Company as of April 26, 2017. 

[Remainder of Page Intentionally Left Blank; Signature Page to Follow] 

 IN WITNESS WHEREOF, the undersigned has caused this Second Amendment to be executed
effective as of the date set forth above. 
  

			
	AXONICS MODULATION TECHNOLOGIES, INC.,
a Delaware corporation

 
			
		
	By:	 	/s/ Raymond W. Cohen
	Name:	 	Raymond W. Cohen
	Title:	 	CEO

 Signature Page to Second Amendment to the Plan 

 AMENDMENT 

TO 
 AXONICS MODULATION
TECHNOLOGIES, INC. 
 2014 STOCK INCENTIVE PLAN 

In accordance with those certain resolutions adopted by the Board of Directors and Stockholders of Axonics Modulation Technologies, Inc., a
Delaware corporation (the “Company”), the 2014 Stock Incentive Plan (the “Plan”) of the Company is hereby further amended as follows: 

1. Section 4.1 of the Plan is hereby amended and restated in its entirety to increase the number of shares reserved for issuance under the
Plan as follows: 
 “4.1 Shares Subject to the Plan. As of the Effective Date, there are 2,648,781 total shares of
Common Stock available for issuance under the Plan. For purposes of this Section 4.1, in the event that (a) all or any portion of any Award granted or offered under the Plan can no longer under any circumstances be exercised or
(b) any shares of Common Stock are reacquired by the Company which were initially the subject of an Award Agreement, the shares of Common Stock allocable to the unexercised portion of such Award, or the shares so reacquired, shall again be
available for grant or issuance under the Plan. The maximum number of shares of Common Stock that may be issued under the Plan as Incentive Options shall be 2,648,781 shares, subject to adjustment as to the number and kind of shares pursuant to
Section 4.2.” 
 2. Unless otherwise expressly provided for in this Amendment to the Plan (the “Amendment”), all
capitalized words, phrases, or defined terms used in this Amendment will have the same meaning ascribed to them in the Plan. 
 3. Except as
expressly set forth in this Amendment, there have been no other changes or modifications to the Plan, and the plan remains otherwise unchanged and in full force and effect. 

4. This Amendment shall be effective as of March 29, 2018. 

I hereby certify that the Plan was duly amended and such Amendment has been duly approved by the Board of Directors of the Company as of
March 29, 2018 and such Amendment has been duly approved by the Stockholders of the Company as of March 29, 2018. 
 [Remainder
of Page Intentionally Left Blank; Signature Page to Follow] 

 IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed effective as of
the date set forth above. 
  

			
	AXONICS MODULATION TECHNOLOGIES, INC., a Delaware corporation
		
	By:	 	/s/ Raymond W. Cohen
	Name:	 	Raymond W. Cohen
	Title:	 	CEO

 Signature Page to Amendment to the Plan

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]